Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,504

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

June 1, 2028

Study Completion Date

December 1, 2028

Conditions
Acute PancreatitisComplicationMortality RateOrgan Failure, Multiple
Interventions
DRUG

Indomethacin SR

Indomethacin SR 50mg given q12h from admission day 1 to day 7

DRUG

Placebos

Similar shape and size suppositories (Placebos) without indomethacin given q12h from admission day 1 to day 7

Trial Locations (17)

100191

RECRUITING

Peking University Sixth Hospital, Beijing

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

102401

RECRUITING

Liangxiang Hospital, Beijing

150001

RECRUITING

Fourth Affiliated Hospital of Harbin Medical University, Harbin

214043

RECRUITING

Wuxi Third People's Hospital, Wuxi

223300

RECRUITING

The Second People's Hospital of Huai'an, Huaian

223800

RECRUITING

Suqian People's Hospital, Suqian

226001

RECRUITING

Nantong First People's Hospital, Nantong

321000

RECRUITING

Jinhua Municipal Central Hospital, Jinhua

323000

RECRUITING

Lishui Municipal Central Hospital, Lishui

411381

RECRUITING

Dengzhou People's Hospital, Dengzhou

473012

RECRUITING

Second People Hospital of Nanyang, Nanyang

550005

RECRUITING

Guiyang Second People's Hospital, Guiyang

610041

RECRUITING

West China Longquan Hospital Sichuan University, Chengdu

810001

RECRUITING

Qinghai University Affiliated Hospital, Xining

830054

RECRUITING

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

071000

RECRUITING

Baoding Seventh Hospital, Baoding

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT03547232 - Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial) | Biotech Hunter | Biotech Hunter